Real-time Estimate
Cboe Europe
04:45:30 2024-05-24 am EDT
|
5-day change
|
1st Jan Change
|
63.98
CHF
|
+2.52%
|
|
-9.21%
|
-13.83%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
928.7
|
2,708
|
2,412
|
320.6
|
867.3
|
778.9
|
-
|
-
|
Enterprise Value (EV)
1 |
1,036
|
2,978
|
2,714
|
723.2
|
1,144
|
1,030
|
1,061
|
1,087
|
P/E ratio
|
-17.7
x
|
-18.9
x
|
-10.1
x
|
-1.61
x
|
10.5
x
|
-9.36
x
|
-36.7
x
|
37.2
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
0.69
x
|
1.83
x
|
1.4
x
|
0.2
x
|
0.9
x
|
0.66
x
|
0.49
x
|
0.39
x
|
EV / Revenue
|
0.76
x
|
2.02
x
|
1.57
x
|
0.45
x
|
1.18
x
|
0.87
x
|
0.67
x
|
0.55
x
|
EV / EBITDA
|
-75.1
x
|
-38
x
|
-19
x
|
-9.31
x
|
-29.8
x
|
-53.7
x
|
30.5
x
|
14.6
x
|
EV / FCF
|
-4.59
x
|
-23.4
x
|
-14
x
|
-3.87
x
|
-9.94
x
|
-15.2
x
|
-23
x
|
-329
x
|
FCF Yield
|
-21.8%
|
-4.27%
|
-7.15%
|
-25.9%
|
-10.1%
|
-6.59%
|
-4.35%
|
-0.3%
|
Price to Book
|
1.67
x
|
5.09
x
|
5.44
x
|
0.84
x
|
2.01
x
|
1.8
x
|
1.86
x
|
1.9
x
|
Nbr of stocks (in thousands)
|
8,680
|
9,568
|
10,240
|
12,543
|
11,760
|
12,482
|
-
|
-
|
Reference price
2 |
107.0
|
283.0
|
235.5
|
25.56
|
73.75
|
62.40
|
62.40
|
62.40
|
Announcement Date
|
3/19/20
|
3/18/21
|
3/24/22
|
3/24/23
|
3/20/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
1,356
|
1,477
|
1,726
|
1,608
|
966.9
|
1,180
|
1,586
|
1,990
|
EBITDA
1 |
-13.8
|
-78.4
|
-142.6
|
-77.7
|
-38.4
|
-19.18
|
34.76
|
74.25
|
EBIT
1 |
-45.7
|
-117.6
|
-193.8
|
-140.3
|
-83.2
|
-62.48
|
-8.487
|
35
|
Operating Margin
|
-3.37%
|
-7.96%
|
-11.23%
|
-8.72%
|
-8.6%
|
-5.29%
|
-0.54%
|
1.76%
|
Earnings before Tax (EBT)
1 |
-50.1
|
-133.2
|
-226.7
|
-169.9
|
-118.7
|
-85.06
|
-34.8
|
11.09
|
Net income
1 |
-52.4
|
-135.6
|
-225.7
|
-171.1
|
82.2
|
-82.91
|
-22.83
|
20.45
|
Net margin
|
-3.87%
|
-9.18%
|
-13.07%
|
-10.64%
|
8.5%
|
-7.02%
|
-1.44%
|
1.03%
|
EPS
2 |
-6.040
|
-14.95
|
-23.40
|
-15.88
|
7.050
|
-6.670
|
-1.701
|
1.679
|
Free Cash Flow
1 |
-225.8
|
-127.3
|
-194.1
|
-187.1
|
-115.1
|
-67.9
|
-46.12
|
-3.3
|
FCF margin
|
-16.65%
|
-8.62%
|
-11.24%
|
-11.63%
|
-11.91%
|
-5.75%
|
-2.91%
|
-0.17%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/19/20
|
3/18/21
|
3/24/22
|
3/24/23
|
3/20/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019 S2
|
2020 S1
|
2020 S2
|
2021 S1
|
2021 Q3
|
2021 Q4
|
2021 S2
|
2022 Q1
|
2022 Q2
|
2022 S1
|
2022 S2
|
2023 Q1
|
2023 Q2
|
2023 S1
|
2023 S2
|
2024 Q1
|
---|
Net sales
1 |
687.1
|
698
|
778.9
|
839.8
|
443.4
|
443.4
|
886.7
|
418.9
|
405.1
|
824
|
784.2
|
402.8
|
235.5
|
463
|
503.9
|
265
|
EBITDA
|
-11.34
|
-24.45
|
-53.95
|
-49.71
|
-
|
-
|
-92.89
|
-
|
-
|
-43.08
|
-34.62
|
-
|
-
|
-28.1
|
-
|
-
|
EBIT
|
-
|
-
|
-
|
-73.11
|
-
|
-
|
-120.7
|
-
|
-
|
-69.45
|
-70.85
|
-
|
-
|
-48.8
|
-
|
-
|
Operating Margin
|
-
|
-
|
-
|
-8.71%
|
-
|
-
|
-13.61%
|
-
|
-
|
-8.43%
|
-9.03%
|
-
|
-
|
-10.54%
|
-
|
-
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-83.04
|
-
|
-
|
-
|
-
|
-
|
Net income
|
-
|
-
|
-
|
-
|
-
|
-
|
-148.7
|
-
|
-
|
-86.09
|
-
|
-
|
-
|
-
|
-
|
-
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-16.77%
|
-
|
-
|
-10.45%
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
|
-
|
-
|
-
|
-8.030
|
-
|
-
|
-
|
-
|
-
|
-8.290
|
-7.590
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/19/20
|
8/19/20
|
3/18/21
|
8/18/21
|
12/24/21
|
3/24/22
|
3/24/22
|
5/18/22
|
8/18/22
|
8/18/22
|
3/24/23
|
5/17/23
|
8/17/23
|
8/17/23
|
3/20/24
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
107
|
270
|
303
|
403
|
277
|
251
|
282
|
308
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-7.768
x
|
-3.444
x
|
-2.123
x
|
-5.181
x
|
-7.208
x
|
-13.11
x
|
8.114
x
|
4.145
x
|
Free Cash Flow
1 |
-226
|
-127
|
-194
|
-187
|
-115
|
-67.9
|
-46.1
|
-3.3
|
ROE (net income / shareholders' equity)
|
-12.3%
|
-28.9%
|
-44.4%
|
-39%
|
-29.2%
|
-19.4%
|
-8.25%
|
0.51%
|
ROA (Net income/ Total Assets)
|
-6.09%
|
-11.9%
|
-17.7%
|
-13.8%
|
-11.6%
|
-7.38%
|
-1.77%
|
2.89%
|
Assets
1 |
859.8
|
1,135
|
1,274
|
1,242
|
-708
|
1,124
|
1,286
|
708.1
|
Book Value Per Share
2 |
63.90
|
55.60
|
43.30
|
30.40
|
36.60
|
34.70
|
33.50
|
32.90
|
Cash Flow per Share
2 |
-9.530
|
-7.440
|
-13.00
|
-9.030
|
-7.490
|
-1.240
|
0.0700
|
3.930
|
Capex
1 |
10.4
|
59.8
|
63.5
|
59.3
|
27.7
|
32.7
|
34.9
|
38.6
|
Capex / Sales
|
0.77%
|
4.05%
|
3.68%
|
3.69%
|
2.87%
|
2.77%
|
2.2%
|
1.94%
|
Announcement Date
|
3/19/20
|
3/18/21
|
3/24/22
|
3/24/23
|
3/20/24
|
-
|
-
|
-
|
Last Close Price
62.4
CHF Average target price
99.24
CHF Spread / Average Target +59.04% Consensus |
1st Jan change
|
Capi.
|
---|
| -13.83% | 852M | | -38.91% | 13.76B | | -31.33% | 11.31B | | -30.66% | 6.32B | | +15.73% | 6.47B | | -8.33% | 6.09B | | +74.00% | 4.95B | | -6.00% | 3.95B | | -14.62% | 3.34B | | -12.02% | 2.92B |
Other Drug Retailers
|